A next-generation multitarget stool DNA test, including assessments of DNA molecular markers and hemoglobin level, was developed to improve the performance of colorectal cancer screening, primarily ...
Building on the wide range of products available from DiaSorin for stool diagnostics, with each DiaSorin LIAISON® Ixt/Arrow™ instrument purchased during February 2014, DiaSorin is providing 2000€ ...
NEW YORK (Reuters Health) - The inexpensive stool tests commonly used to screen for colon cancer can be more effective, and much less costly, than newer tests that look for certain genetic markers in ...
Mayo Clinic study shows stool DNA testing for colorectal cancer has potential, but challenges remain
ROCHESTER, Minn. -- The first generation of a stool DNA test to identify early colorectal cancer has limitations, according to a Mayo Clinic-led study published in the Oct. 7, 2008, issue of Annals of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results